Report Detail

Pharma & Healthcare Global Non-prescription Drugs Market Professional Survey Report 2019

  • RnM3747878
  • |
  • 14 September, 2019
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.

The global Non-prescription Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Non-prescription Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-prescription Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Non-prescription Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Non-prescription Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Shire
Boehringer Ingelheim
Takeda

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Brand Drugs
Generic Drug

Segment by Application
Hospital
Clinic
Other


Table of Contents

    Executive Summary

      1 Industry Overview of Non-prescription Drugs

      • 1.1 Definition of Non-prescription Drugs
      • 1.2 Non-prescription Drugs Segment by Type
        • 1.2.1 Global Non-prescription Drugs Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Brand Drugs
        • 1.2.3 Generic Drug
      • 1.3 Non-prescription Drugs Segment by Applications
        • 1.3.1 Global Non-prescription Drugs Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Other
      • 1.4 Global Non-prescription Drugs Overall Market
        • 1.4.1 Global Non-prescription Drugs Revenue (2014-2025)
        • 1.4.2 Global Non-prescription Drugs Production (2014-2025)
        • 1.4.3 North America Non-prescription Drugs Status and Prospect (2014-2025)
        • 1.4.4 Europe Non-prescription Drugs Status and Prospect (2014-2025)
        • 1.4.5 China Non-prescription Drugs Status and Prospect (2014-2025)
        • 1.4.6 Japan Non-prescription Drugs Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Non-prescription Drugs Status and Prospect (2014-2025)
        • 1.4.8 India Non-prescription Drugs Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Non-prescription Drugs
      • 2.3 Manufacturing Process Analysis of Non-prescription Drugs
      • 2.4 Industry Chain Structure of Non-prescription Drugs

      3 Development and Manufacturing Plants Analysis of Non-prescription Drugs

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Non-prescription Drugs Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Non-prescription Drugs
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Non-prescription Drugs Production and Capacity Analysis
      • 4.2 Non-prescription Drugs Revenue Analysis
      • 4.3 Non-prescription Drugs Price Analysis
      • 4.4 Market Concentration Degree

      5 Non-prescription Drugs Regional Market Analysis

      • 5.1 Non-prescription Drugs Production by Regions
        • 5.1.1 Global Non-prescription Drugs Production by Regions
        • 5.1.2 Global Non-prescription Drugs Revenue by Regions
      • 5.2 Non-prescription Drugs Consumption by Regions
      • 5.3 North America Non-prescription Drugs Market Analysis
        • 5.3.1 North America Non-prescription Drugs Production
        • 5.3.2 North America Non-prescription Drugs Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Non-prescription Drugs Import and Export
      • 5.4 Europe Non-prescription Drugs Market Analysis
        • 5.4.1 Europe Non-prescription Drugs Production
        • 5.4.2 Europe Non-prescription Drugs Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Non-prescription Drugs Import and Export
      • 5.5 China Non-prescription Drugs Market Analysis
        • 5.5.1 China Non-prescription Drugs Production
        • 5.5.2 China Non-prescription Drugs Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Non-prescription Drugs Import and Export
      • 5.6 Japan Non-prescription Drugs Market Analysis
        • 5.6.1 Japan Non-prescription Drugs Production
        • 5.6.2 Japan Non-prescription Drugs Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Non-prescription Drugs Import and Export
      • 5.7 Southeast Asia Non-prescription Drugs Market Analysis
        • 5.7.1 Southeast Asia Non-prescription Drugs Production
        • 5.7.2 Southeast Asia Non-prescription Drugs Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Non-prescription Drugs Import and Export
      • 5.8 India Non-prescription Drugs Market Analysis
        • 5.8.1 India Non-prescription Drugs Production
        • 5.8.2 India Non-prescription Drugs Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Non-prescription Drugs Import and Export

      6 Non-prescription Drugs Segment Market Analysis (by Type)

      • 6.1 Global Non-prescription Drugs Production by Type
      • 6.2 Global Non-prescription Drugs Revenue by Type
      • 6.3 Non-prescription Drugs Price by Type

      7 Non-prescription Drugs Segment Market Analysis (by Application)

      • 7.1 Global Non-prescription Drugs Consumption by Application
      • 7.2 Global Non-prescription Drugs Consumption Market Share by Application (2014-2019)

      8 Non-prescription Drugs Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer Non-prescription Drugs Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer Non-prescription Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Roche
        • 8.2.1 Roche Non-prescription Drugs Production Sites and Area Served
        • 8.2.2 Roche Product Introduction, Application and Specification
        • 8.2.3 Roche Non-prescription Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Sanofi
        • 8.3.1 Sanofi Non-prescription Drugs Production Sites and Area Served
        • 8.3.2 Sanofi Product Introduction, Application and Specification
        • 8.3.3 Sanofi Non-prescription Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Johnson & Johnson
        • 8.4.1 Johnson & Johnson Non-prescription Drugs Production Sites and Area Served
        • 8.4.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.4.3 Johnson & Johnson Non-prescription Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Merck & Co. (MSD)
        • 8.5.1 Merck & Co. (MSD) Non-prescription Drugs Production Sites and Area Served
        • 8.5.2 Merck & Co. (MSD) Product Introduction, Application and Specification
        • 8.5.3 Merck & Co. (MSD) Non-prescription Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Novartis
        • 8.6.1 Novartis Non-prescription Drugs Production Sites and Area Served
        • 8.6.2 Novartis Product Introduction, Application and Specification
        • 8.6.3 Novartis Non-prescription Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 AbbVie
        • 8.7.1 AbbVie Non-prescription Drugs Production Sites and Area Served
        • 8.7.2 AbbVie Product Introduction, Application and Specification
        • 8.7.3 AbbVie Non-prescription Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Gilead Sciences
        • 8.8.1 Gilead Sciences Non-prescription Drugs Production Sites and Area Served
        • 8.8.2 Gilead Sciences Product Introduction, Application and Specification
        • 8.8.3 Gilead Sciences Non-prescription Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 GlaxoSmithKline (GSK)
        • 8.9.1 GlaxoSmithKline (GSK) Non-prescription Drugs Production Sites and Area Served
        • 8.9.2 GlaxoSmithKline (GSK) Product Introduction, Application and Specification
        • 8.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Amgen
        • 8.10.1 Amgen Non-prescription Drugs Production Sites and Area Served
        • 8.10.2 Amgen Product Introduction, Application and Specification
        • 8.10.3 Amgen Non-prescription Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 AstraZeneca
      • 8.12 Bristol-Myers Squibb
      • 8.13 Eli Lilly
      • 8.14 Teva
      • 8.15 Bayer
      • 8.16 Novo Nordisk
      • 8.17 Allergan
      • 8.18 Shire
      • 8.19 Boehringer Ingelheim
      • 8.20 Takeda

      9 Development Trend of Analysis of Non-prescription Drugs Market

      • 9.1 Global Non-prescription Drugs Market Trend Analysis
        • 9.1.1 Global Non-prescription Drugs Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Non-prescription Drugs Regional Market Trend
        • 9.2.1 North America Non-prescription Drugs Forecast 2019-2025
        • 9.2.2 Europe Non-prescription Drugs Forecast 2019-2025
        • 9.2.3 China Non-prescription Drugs Forecast 2019-2025
        • 9.2.4 Japan Non-prescription Drugs Forecast 2019-2025
        • 9.2.5 Southeast Asia Non-prescription Drugs Forecast 2019-2025
        • 9.2.6 India Non-prescription Drugs Forecast 2019-2025
      • 9.3 Non-prescription Drugs Market Trend (Product Type)
      • 9.4 Non-prescription Drugs Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Non-prescription Drugs Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Non-prescription Drugs. Industry analysis & Market Report on Non-prescription Drugs is a syndicated market report, published as Global Non-prescription Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Non-prescription Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,796.50
        4,194.75
        5,593.00
        3,276.00
        4,914.00
        6,552.00
        550,830.00
        826,245.00
        1,101,660.00
        292,215.00
        438,322.50
        584,430.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report